Nikko Asset Management Americas, Inc. Intellia Therapeutics, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.95 Billion
- Q4 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,992,663 shares of NTLA stock, worth $28.8 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
2,992,663
Previous 3,148,397
4.95%
Holding current value
$28.8 Million
Previous $64.7 Million
46.07%
% of portfolio
0.39%
Previous 0.75%
Shares
26 transactions
Others Institutions Holding NTLA
# of Institutions
333Shares Held
90.3MCall Options Held
537KPut Options Held
818K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$121 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$98.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$92.5 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$50.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.99MShares$28.8 Million0.02% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $733M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...